Could a popular diabetes drug also protect hearts in type 1?
NCT ID NCT05819138
Summary
This study is testing whether the medication semaglutide can improve heart and kidney health in adults with type 1 diabetes. Researchers want to see if it reduces artery stiffness and improves how the body uses insulin, similar to benefits seen in type 2 diabetes. The trial will enroll 60 adults aged 18-49 who use an insulin pump. This is an experimental use of the drug, which is not yet approved for type 1 diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Colorado Anschutz Medical Campus
RECRUITINGAurora, Colorado, 80045, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Washington Medicine Diabetes Institute (UWMDI)
RECRUITINGSeattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.